Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB11786InvestigationalSmall molecule
Pefcalcitol has been investigated for the basic science of Psoriasis.
- Mechanism
- Curator reviewed
Pharmacologically active on Vitamin D3 receptor
- Formula / weight
- C26H34F5NO4 · 519.553 g/mol (avg)
- Code names
- M-518101
Resolves to
Structure
InChIKey
SVCSMAZYWOQCBW-NVJMFHFGSA-NSMILESC[C@H](OCC(=O)NCC(F)(F)C(F)(F)F)C1=CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=CTargets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Pefcalcitol, and which of those have an active Phase 3 trial?